Lower respiratory viral illnesses: Improved diagnosis by molecular methods and clinical impact

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 11, 2004, Pages 1197-1203

  Garbino, Jorge ^b   Gerbase, Margaret W ^b   Wunderli, Werner ^b   Deffernez, Christelle ^b   Thomas, Yves ^b   Rochat, Thierry ^b   Ninet, Beatrice ^b   Schrenzel, Jacques ^b   Yerly, Sabine ^b   Perrin, Luc ^b   Soccal, Paola M ^b   Nicod, Laurent ^b   Kaiser, Laurent ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Bronchoalveolar lavage; Lung transplantation; Respiratory syncytial virus; Respiratory viruses; Rhinovirus

Indexed keywords

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CELL CULTURE; CHILD; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEGIONELLA PNEUMOPHILA; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MORBIDITY; MYCOPLASMA PNEUMONIAE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VIRUS DETECTION; VIRUS INFECTION;

BRONCHOALVEOLAR LAVAGE FLUID; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; LUNG TRANSPLANTATION; RESPIRATORY TRACT INFECTIONS; SWITZERLAND; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 9644290753     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200406-781OC     Document Type: Article

References (44)

1. File TM. Community-acquired pneumonia. Lancet 2003;362:1991-2001.
2. Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, Hough LJ, Obrosky DS, Schulz R, Ricci EM, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999;159:970-980.
3. Garbino J, Sommer R, Gerber A, Regamey C, Vernazza P, Genne D, Dur P, Rothen M, Unger JP, Lew D. Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland. Int J Infect Dis 2002;6:288-293.
4. Freymuth F, Vabret A, Galateau-Salle F, Ferey J, Eugene G, Petitjean J, Gennetay E, Brouard J, Jokik M, Duhamel JF, et al. Detection of respiratory syncytial virus, parainfluenzavirus 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridization. Clin Diagn Virol 1997;8:31-40.
5. Fan J, Henrickson KJ, Savatski LL. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin Infect Dis 1998;s26:1397-1402.
6. Kaiser L, Garbino J, Deffernez C, Thomas Y, Gerbase M, Perrin L, Gasche-Soccal P, Nicod L, Rochat T, Wunderli W. Detection of respiratory virus and atypical bacteria from BAL in hospitalized patients with severe respiratory infection and impact on diseases severity [abstract]. American Society of Microbiology, 43th Interscience Conference Antimicrobial Agents and Chemotherapy. Chicago, September 14-17, 2003.
7. Deffernez C, Wunderli W, Thomas Y, Yerly S, Perrin L, Kaiser L. Amplicon sequencing and improved detection of human rhinovirus in respiratory samples. J Clin Microbiol 2004;42:3212-3218.
8. Thomas Y, Kaiser L, Hagmann R, Burckhardt-Batista I, Wunderli W. Influenza monitoring by different methods in a surveillance network [abstract]. Influenza vaccine for the world. Lisbon, Portugal, May 24-26, 2004.
9. Malcolm E, Arruda E, Hayden FG, Kaiser L. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J Clin Virol 2001;21:9-16.
10. Garbino J, Gerbase MW, Wunderli W, Kolarova L, Nicod L, Rochat T, Kaiser L. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients. Chest 2004;125:1033-1039.
11. Kaiser L, Briones MS, Hayden FG. Performance of virus isolation and Directigen flu A to detect influenza A virus in experimental human infection. J Clin Virol 1999;14:191-197.
12. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
13. Wright PF, Webster RG. Othomyxoviruses. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 1533-1579.
14. Yousuf HM, Englund J, Couch R, Rolston K, Luna M, Goodrich J, Lewis V, Mirza NQ, Andreeff M, Koller C, et al. Influenza among hospitalized adults with leukemia. Clin Infect Dis 1997;24:1095-1099.
15. Randolph AG, Wang EE. Ribavirin for respiratory syncytial virus lower respiratory tract infection: a systematic overview. Arch Pediatr Adolesc Med 1996;150:942-947.
16. Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I, Przepiorka D, Lewis VA, Mirza N, Yousuf H, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778-782.
17. Garantziotis S, Howell DN, McAdams HP, Davis RD, Henshaw NG, Palmer SM. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 2001;119:1277-1280.
18. Vilchez R, McCurry K, Dauber J, Iacono A, Keenan R, Griffith B, Kusne S. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 2002; 73:1075-1078.
19. Wendt CH, Fox JM, Hertz MI. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 1995;14:479-485.
20. Khalifah AP, Hachem RR, Chakinala MM, Schechtman B, Patterson A, Schuster DP, Mohanakumar T, Trulock EP, Walter MJ. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004;170:181-187.
21. Nicholson KG, Kent J, Hammersley V, Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ 1996;313:1119-1123.
22. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-1229.
23. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, Cunningham A, Robinson BS, Myint SH, Ward ME, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996;154(3 Pt. 1):654-660.
24. Wald TG, Shult P, Krause P, Miller BA, Drinka P, Gravenstein S. A rhinovirus outbreak among residents of a long-term care facility. Ann Intern Med 1995;123:588-593.
25. Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, Meyer J, Lackie PM, Sanderson G, Holgate ST, et al. Rhinoviruses infect the lower airways. J Infect Dis 2000;181:1875-1884.
26. Ghosh S, Champlin R, Couch R, Englund J, Raad I, Malik S, Luna M, Whimbey E. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis 1999;29:528-532.
27. Ison MG, Hayden FG, Kaiser L, Corey L, Boeckh M. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis 2003;36:1139-1143.
28. Hayden FG. Rhinovirus and the lower respiratory tract. Rev Med Virol 2004;14:17-31.
29. Papadopoulos NG. Do rhinoviruses cause pneumonia in children? Paediatr Respir Rev 2004;5:S191-S195.
30. Gagneur A, Sizun J, Vallet S, Legr MC, Picard B, Talbot PJ. Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study. J Hosp Infect 2002;51: 59-64.
31. Falsey AR, Walsh EE, Hayden FG. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J Infect Dis 2002;185: 1338-1341.
32. Vabret A, Mourez T, Gouarin S, Petitjean J, Freymuth F. An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Clin Infect Dis 2003;36:985-989.
33. Van Der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B. Identification of a new human coronavirus. Nat Med 2004;10:368-373.
34. Sirinarumitr T, Paul PS, Halbur PG, Kluge JP. An overview of immunological and genetic methods for detecting swine coronaviruses, transmissible gastroenteritis virus, and porcine respiratory coronavirus in tissues. Adv Exp Med Biol 1997;412:37-46.
35. Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon H, Osterhaus AD. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 2004;101:6212-6216.
36. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE Jr. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350:443-450.
37. van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R, Osterhaus AD, Fouchier RA. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 2003;188:1571-1577.
38. Boivin G, De Serres G, Cote S, Gilca R, Abed Y, Rochette L, Bergeron MG, Dery P. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 2003;9:634-640.
39. Cane PA, van den Hoogen BG, Chakrabarti S, Fegan CD, Osterhaus AD. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant 2003;31:309-310.
40. Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003;187:785-790.
41. Dowell SF, Anderson LJ, Gary HE Jr, Erdman DD, Plouffe JF, File TM Jr, Marston BJ, Breiman RF. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996;174:456-462.
42. Simoes EA. Respiratory syncytial virus infection. Lancet 1999;354:847-852.
43. Kaiser L, Crump CE, Hayden FG. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antivir Res 2000;47:215-220.
44. Ison MG, Gnann JW Jr, Nagy-Agren S, Treannor J, Paya C, Steigbigel R, Elliott M, Weiss HL, Hayden FG, NIAID Collaborative Antiviral Study Group. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antivir Ther 2003;8:183-190.